Haim Biotech "Approval for Manufacturing COVID-19 In Vitro Diagnostic Medical Devices"

[Asia Economy Reporter Hyungsoo Park] Amid the prolonged novel coronavirus infection (COVID-19) situation, NCtron announced on the 12th that its affiliate, Haim Biotech, has obtained manufacturing approval for COVID-19 in vitro diagnostic medical devices.

Haim Biotech received manufacturing approval for COVID-19 in vitro diagnostic medical devices from the Ministry of Food and Drug Safety. The product approved for manufacturing by Haim Biotech is a diagnostic kit that can immediately determine COVID-19 infection status outside the body.

NCtron possesses large-area antibacterial films and antibacterial pouches made with copper nano materials. With the addition of Haim Biotech's in vitro diagnostic medical devices, the company has secured a diverse product lineup to respond to the COVID-19 situation.

A company representative said, "As COVID-19 spreads worldwide, NCtron is also releasing various quarantine products," adding, "With Haim Biotech receiving manufacturing approval from the Ministry of Food and Drug Safety, we can respond more actively than before."

They continued, "We will further expand related businesses and introduce products that consumers can easily use while boasting excellent efficacy."

This content was produced with the assistance of AI translation services.